66 related articles for article (PubMed ID: 10370855)
1. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
3. Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris.
Ahmed AR; Gürcan HM
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1073-9. PubMed ID: 21143649
[TBL] [Abstract][Full Text] [Related]
4. Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Kerr J; Quinti I; Eibl M; Chapel H; Späth PJ; Sewell WA; Salama A; van Schaik IN; Kuijpers TW; Peter HH
Front Immunol; 2014; 5():629. PubMed ID: 25566244
[TBL] [Abstract][Full Text] [Related]
5. European consensus proposal for immunoglobulin therapies.
Sewell WA; Kerr J; Behr-Gross ME; Peter HH;
Eur J Immunol; 2014 Aug; 44(8):2207-14. PubMed ID: 24975475
[TBL] [Abstract][Full Text] [Related]
6. Haemolytic disease of the fetus and newborn.
de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
[TBL] [Abstract][Full Text] [Related]
7. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
[TBL] [Abstract][Full Text] [Related]
10. Quality control for intravascular intrauterine transfusion using cumulative sum (CUSUM) analysis for the monitoring of individual performance.
Lindenburg IT; Wolterbeek R; Oepkes D; Klumper FJ; Vandenbussche FP; van Kamp IL
Fetal Diagn Ther; 2011; 29(4):307-14. PubMed ID: 21304232
[TBL] [Abstract][Full Text] [Related]
11. The Management and Diagnosis of Anti-NMDA Receptor Autoimmune Encephalitis in Pregnant Women: A Case Report and Literature Review.
Potorac A; Varlas VN; Borș RG; Baroș A; Cirstoiu M
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138213
[No Abstract] [Full Text] [Related]
12. Anti N-methyl-D-aspartate receptor (NMDAr) encephalitis during pregnancy: A case report.
Dono F; Evangelista G; Consoli S; Scorrano G; Russo M; di Pietro M; Onofrj M; Sensi SL; Anzellotti F
Epilepsy Behav Rep; 2022; 19():100535. PubMed ID: 35520953
[TBL] [Abstract][Full Text] [Related]
13. Clinical uses of intravenous immunoglobulin in pregnancy.
Clark AL
Clin Obstet Gynecol; 1999 Jun; 42(2):368-80. PubMed ID: 10370855
[TBL] [Abstract][Full Text] [Related]
14. Clinical uses of intravenous immunoglobulin in pregnancy.
Clark AL; Gall SA
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):241-53. PubMed ID: 9024121
[TBL] [Abstract][Full Text] [Related]
15. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises.
Branch DW; Porter TF; Paidas MJ; Belfort MA; Gonik B
J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S133-8. PubMed ID: 11586281
[TBL] [Abstract][Full Text] [Related]
16. Safety of anti-D during pregnancy.
Cromwell C; Tarantino M; Aledort LM
Am J Hematol; 2009 Apr; 84(4):261-2. PubMed ID: 19291729
[No Abstract] [Full Text] [Related]
17. Immune thrombocytopenic purpura in pregnancy: a reappraisal of obstetric management and outcome.
Gasim T
J Reprod Med; 2011; 56(3-4):163-8. PubMed ID: 21542536
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
